Group ECOG

Related by string. * grouping . group . Groups . groups . grouped . GROUP . grouper . Grouper . GROUPS . Grouping . Grouped : Permissions Group Inc. . NASDAQ OMX Group . Lloyds Banking Group . Nuclear Suppliers Group . SITE Intelligence Group . Group Plc . Avis Budget Group . CIT Group . Mizuho Financial Group . InterContinental Hotels Group . Carrier Strike Group / ECoG : ECOG PS . Governance ECoG . ECOG * *

Related by context. Frequent words. (Click for all words.) 79 Cooperative Oncology 68 ECOG 65 Gynecologic Oncology Group 61 EORTC 59 registrational trial 59 RTOG 59 neoadjuvant 58 NSABP 58 relapsed refractory multiple myeloma 57 refractory multiple myeloma 57 Amrubicin 57 randomized Phase III 57 SWOG 57 placebo controlled clinical 57 plus methotrexate 57 HER2 positive metastatic breast 57 Solid Tumors 57 plus dexamethasone 56 COPAXONE R 56 FOLFIRI 56 RG# [001] 56 tocilizumab 56 PRECiSE 56 National Surgical Adjuvant 56 TORISEL 56 mycophenolate mofetil 56 axitinib 55 sunitinib 55 insulin glargine 55 Lenalidomide 55 plus prednisone 55 mg kg dose 55 active comparator 55 pemetrexed 55 decitabine 55 glatiramer acetate 54 HER2 negative 54 pertuzumab 54 systemic lupus erythematosus SLE 54 Fludara 54 substudy 54 myelodysplastic syndromes MDS 54 adalimumab 54 Phenoptin 54 nab paclitaxel 54 COPAXONE ® 54 neoadjuvant chemotherapy 54 Taxotere ® 54 Phase III Clinical Trial 54 androgen deprivation 54 XELOX 54 Multicenter 53 mg BID 53 multicenter randomized 53 Torisel 53 virologic response 53 Chronic Lymphocytic Leukemia 53 ataluren 53 azacitidine 53 neoadjuvant therapy 53 FOLFOX 53 Phase 2a trial 53 temsirolimus 53 Phase III randomized 53 sorafenib 53 allogeneic stem cell 53 ziprasidone 52 achieved statistical significance 52 metastatic renal cell carcinoma 52 vandetanib 52 prospective observational 52 vinorelbine 52 chronic lymphocytic leukemia CLL 52 cytogenetic response 52 hepatocellular carcinoma HCC 52 ADXS# 52 unresectable 52 Irinotecan 52 multicenter study 52 Phase 2a clinical 52 Cancer EORTC 52 distant metastases 52 J Clin Oncol 51 HCV infected 51 genotypic 51 chemoradiotherapy 51 bortezomib 51 Carfilzomib 51 breast carcinoma 51 multicenter 51 hepatocellular carcinoma 51 NSCLC 51 lupus nephritis 51 T2DM 51 Pirfenidone 51 cutaneous T cell 51 Phase 1b trial 51 QoL 51 Virulizin R 51 BAY #-# 51 prospective randomized controlled

Back to home page